SHANGHAI, China, May 09, 2019 (GLOBE NEWSWIRE) -- Zai Lab Limited ZLAB, a China and U.S.-based innovative commercial stage biopharmaceutical company, today announced that members of the senior management team will participate in four upcoming conferences in May. Details of the conferences are as follows:
- J.P. Morgan Global China Summit 2019
Date: May 8-9, 2019
Location: China World Summit Wing, Beijing
- Bank of America Merrill Lynch Healthcare Conference 2019
Date: May 14-16, 2019
Location: Encore Hotel, Las Vegas
- Macquarie Greater China Conference
Date: May 16-17, 2019
Location: Island Shangri-La Hotel, Hong Kong
- Bank of America Merrill Lynch Innovative China Conference 2019
Date: May 27-28, 2019
Location: Futian Shangri-La Hotel, Shenzhen
Individuals may access more information on the Zai Lab website at www.zailaboratory.com under "Events & Presentations" in the "Investors" section.
About Zai Lab
Zai Lab ZLAB is a China and US-based innovative commercial stage biopharmaceutical company focused on bringing transformative medicines for cancer, autoimmune and infectious diseases to patients in China and around the world. Zai Lab's experienced team has secured partnerships with leading global biopharma companies, generating a broad pipeline of innovative drug candidates targeting the fast-growing segments of China's pharmaceutical market and addressing unmet medical needs. Zai Lab's vision is to become a fully integrated biopharmaceutical company, discovering, developing, manufacturing and commercializing its partners' and its own products in order to impact human health worldwide.
Contact:
Zai Lab
Billy Cho, CFO
+86 137 6151 2501
billy.cho@zailaboratory.com
Media: Nancie Steinberg / Robert Flamm
Burns McClellan, on behalf of Zai Lab
212-213-0006, ext. 318 / 364, nsteinberg@burnsmc.com / rflamm@burnsmc.com
Investors: Jill Steier
Burns McClellan, on behalf of Zai Lab
212-213-0006, ext. 367, jsteier@burnsmc.com
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
